SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing shares are under pressure after the FAA said certification of the 737 MAX 10 would be delayed while it reviews a flight-guidance software issue. Traders are split between viewing the glitch as a manageable, previously disclosed fix and worrying that renewed regulatory scrutiny could prolong certification delays and reinforce broader concerns about Boeings execution.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Positive Phase 3 DAYBREAK results in wet AMDboth experimental treatments met their primary goals against Eylea, and Zenkuda showed potential for longer dosing intervalssparked a sharp rally; Kodiak plans an FDA filing for Zenkuda. Traders celebrated the clinical progress and short squeeze, while others questioned the valuation and competitive edge and warned that Kodiaks precommercial status and funding needs could lead to dilution.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for a U.S. Army program to develop next-generation 10 kV silicon-carbide power technology is driving discussion, with traders viewing it as meaningful validation of the companys technology. The bullish reaction is tempered by debate over the awards undisclosed financial terms and whether the prototype work will translate into near-term revenue.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

AstraZenecas planned $2 billion equity investment in Summit, paired with an ivonescimab combination-trial collaboration, is drawing attention as a major source of financing and pharma validation ahead of the FDA decision. Traders are broadly enthusiastic, though some caution that the deal is an investmentnot an acquisitionwhile buyout and short-squeeze expectations remain speculative.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIAs record increase to its share-repurchase authorization is driving attention, with traders viewing it as a confidence signal and a source of support amid broader market weakness. Others question whether the authorization will translate into actual purchases and note that the stock has struggled to sustain its gains near resistance.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Traders linked CLFs sharp decline to a proposed Mesabi Metallics steel plant in Iowa, with bearish posts arguing the added capacity could intensify competition. The community is divided over whether the project will actually be built; some also point to Hamilton production cuts and layoffs as reasons for concern, while others see the selloff as overdone.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

Starships first orbital flight and deployment of 26 Starlink V3 satellites are driving attention, though an engine problem cut the mission short. Traders are split between viewing the payload deployment as a major Starlink growth milestone and criticizing the flights technical issues, while the stocks decline has prompted sell-the-news and valuation debate.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

OCUL is selling off as traders react to positive late-stage wet AMD updates from competitors, particularly Kodiak Sciences, raising concerns about competition for Oculars AXPAXLI. Bulls argue AXPAXLIs durability and trial results remain differentiated and call the decline an overreaction, while skeptics see the competitor data as a threat to its prospects.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

HBAR is drawing attention after a sharp, high-volume rally and a breakout that traders see as a possible trend reversal. Many connect the move to Hederas enterprise-AI story, citing IBM and NVIDIA-related developments, while others say the catalyst is unclear and warn that the rally could give way to profit-taking.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is drawing attention as a publicly traded proxy for private AI companies, especially Anthropic, with traders speculating about an upcoming IPO. That optimism is competing with concerns about shares becoming freely tradable, a disputed NAV and premium, and claims that the fund reduced its Anthropic exposurefueling sharp swings and disagreement over whether IPO hype can offset selling pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amprius award of up to a federal defense grant to expand U.S. production of high-energy batteries for drones is the main catalyst, with bullish traders viewing it as strategic validation and a path to greater capacity. Others caution that the expansion is years away and does not itself confirm customer orders or near-term revenue; the stocks sharp fade after an initial rally has fueled debate over the news immediate financial impact.

Amprius Secures $75 Million Grant for American High-Energy Density Battery Production

Amprius Technologies (Amprius or the Company) (NYSE: AMPX), a leader in high-performance batteries, has been awarded a grant of up to $75 million from the U.S. Department of War (DoW) to retrofit an existing domestic production line from EV batteries to high-energy density cells for unmanned aerial...

Amprius Introduces SiCore500 High Energy Density Cells for Unmanned Aviation

Amprius Technologies ("Amprius" or the "Company") (NYSE: AMPX), a leader in silicon anode lithium-ion batteries, today announced a new 500 Wh/kg SiCore cell, designed for long-endurance aviation. The cell delivers 500 Wh/kg at a 1C continuous discharge rate and can be produced on conventional...

Amprius Sets September 2026 Events Schedule

Amprius Technologies, Inc. (Amprius or the Company) (NYSE: AMPX), a leader in silicon anode lithium-ion batteries, today announced its schedule for September appearances and activities.Commercial UAV Expo 2026Date: September 1-3, 2026Location: Caesars Forum; Las Vegas, NVEvent Details: Amprius will...

AMPX Q2 Earnings Call Highlights Higher Guidance and Drone Demand

Amprius raises 2026 revenue and margin guidance as drone demand, European sales and manufacturing economics strengthen visibility.

Amprius Technologies (AMPX) Reports Q2 Loss, Beats Revenue Estimates

Amprius (AMPX) delivered earnings and revenue surprises of 0.00% and +17.78%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Amprius Technologies Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Amprius Technologies, Inc. ("Amprius" or the "Company") (NYSE: AMPX), a leader in silicon anode lithium-ion batteries, today announced financial results for the second quarter ended June 30, 2026, and discussed recent business developments. Revenue for the second quarter of 2026 was $34.0 million...

Amprius Technologies Set to Report Q2 Earnings: What's in the Cards?

AMPX heads into Q2 results with revenues expected to surge 92.6% y/y, fueled by customer wins and rising SiCore battery adoption.

Duos Technologies Group, Inc. (DUOT) Moves 5.8% Higher: Will This Strength Last?

Duos Technologies Group, Inc. (DUOT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Amprius Technologies Sets Upcoming Conference Schedule

Amprius Technologies, Inc. ("Amprius"), (NYSE: AMPX), a leader in silicon anode lithium-ion batteries, today announced that it will participate in the upcoming conferences:Canaccord Genuity 46th Annual Growth ConferenceDate: Aug. 11-12, 2026Location: InterContinental Boston; Boston, MAEvent...

Amprius Technologies Becomes Oversold (AMPX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me...

Amprius Technologies (NYSE: AMPX) is at the forefront of transforming electric mobility with its revolutionary Silicon Anode lithium-ion battery. The company is powering a new era, offering a drop-in replacement for conventional lithium-ion batteries while delivering up to 80% higher energy density. Leveraging its patented silicon anode platform, the company’s commercially proven batteries deliver unmatched performance – ultra-high energy density, high power density, extreme fast charge rate capability, wide operating temperature, and long cycle life.

Amprius Technologies Inc

Why Did Amprius Stock Surge Over 11% Today?

Equity

Extremely Bullish Sentiment

Adding risk (buying more)

Trimming/taking profits

Rotating into safer assets

Staying the course, no changes

We&#39;re about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Stocktwits

We're about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Microsoft Corp

Meta Platforms Inc

SELLAS Life Sciences Group Inc

Alphabet Inc Class A

CoreWeave Inc

Stocktwits Polls

Investors are buzzing over a $75 million government grant aimed at scaling drone battery production for domestic defense needs.

Traders are venting frustration over intraday price dips and alleged algorithmic manipulation following the positive grant news.

Long-term bulls are focusing on high-density silicon-anode tech as a core component for future robotics, aviation, and defense markets.

The sentiment is shifting toward upcoming earnings as a potential catalyst for sustained price momentum above key resistance levels.

AMPX Amprius Technologies Inc